The ENDIS already confirmed a positive effect of adjuvant therapy with SGLT-2 inhibitors and GLP-1 analogs on endothelial function in T1DM patients based on various functional tests [22]. The gene discussed is GLP1R; the disease is type 1 diabetes mellitus.